Combining a Ru(ii)-arene complex with a NO-releasing nitrate-ester ligand generates cytotoxic activity.

about

Combining a Ru(ii)-arene complex with a NO-releasing nitrate-ester ligand generates cytotoxic activity.

Item

http://www.wikidata.org/entity/Q38734166

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Combining a Ru(ii)-arene compl ...... generates cytotoxic activity.

@en

type

Item

label

Combining a Ru(ii)-arene compl ...... generates cytotoxic activity.

@en

prefLabel

Combining a Ru(ii)-arene compl ...... generates cytotoxic activity.

@en

P1476

Combining a Ru(ii)-arene compl ...... generates cytotoxic activity.

@en

P2093

Charles J Walsby

http://www.w3.org/2001/XMLSchema#string

Jian Zhao

http://www.w3.org/2001/XMLSchema#string

Kathleen E Prosser

http://www.w3.org/2001/XMLSchema#string

Shradha P Zakharia

http://www.w3.org/2001/XMLSchema#string

Stephanie W Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Nitric oxide and peroxynitrite in health and disease

Kinetics of aquation and anation of ruthenium(II) arene anticancer complexes, acidity and X-ray structures of aqua adducts.

Nitric oxide donors: chemical activities and biological applications.

Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts.

Highly selective binding of organometallic ruthenium ethylenediamine complexes to nucleic acids: novel recognition mechanisms.

The role of glutathione in cancer.

From bench to bedside--preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A).

Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligands.

The role of nitric oxide in cancer.

Nitrates and NO release: contemporary aspects in biological and medicinal chemistry.

P304

18079-18083

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C6DT03661A

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27805196

http://www.w3.org/2001/XMLSchema#string